Goodman Co., the Japanese developer, manufacturer and distributor of vascular interventional devices, announced that it has completed the acquisition of Lightlab Imaging, LLC.
Goodman Co., the Japanese developer, manufacturer and distributor of vascular interventional devices, announced that it has completed the acquisition of Lightlab Imaging, LLC.
Headquartered in Boston, Massachusetts, Lightlab Imaging is focused on the development of OCT (optical coherence technology), a new high-resolution high-speed imaging modality that uses advanced photonics for imaging and tissue characterization.
When fully exploited, this technology has the potential to dramatically change the way physicians, researchers and scientists view and understand the human body to better diagnose and treat disease. Current imaging is accomplished using near-infrared wavelengths (1300 nm) within a 0.006in optical fiber and can achieve resolution on the order of approximately 4-20 microns.
The potential applications for this technology are numerous and include cardiovascular imaging, cancer detection, vulnerable plaque detection, as well as industrial applications.
"The use of OCT for cancer detection is particularly important because it has the potential to more precisely identify and guide biopsy procedures, reduce the number of biopsies and make earlier and more accurate diagnosis possible, thereby, improving the quality of life for patients." said Akira Yamamoto, President of Goodman.
Lightlab Imaging will become a wholly owned subsidiary of Goodman and will be included in its consolidated accounts.
